share_log

Despite Lower Earnings Than Five Years Ago, Labcorp Holdings (NYSE:LH) Investors Are up 65% Since Then

Despite Lower Earnings Than Five Years Ago, Labcorp Holdings (NYSE:LH) Investors Are up 65% Since Then

儘管盈利較五年前下降,紐交所(LH)Labcorp控股的投資者自那時起漲幅達65%
Simply Wall St ·  11/21 06:23

When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Furthermore, you'd generally like to see the share price rise faster than the market. But Labcorp Holdings Inc. (NYSE:LH) has fallen short of that second goal, with a share price rise of 37% over five years, which is below the market return. Looking at the last year alone, the stock is up 12%.

當你長期購買和持有股票時,你肯定希望它能提供正回報。此外,您通常希望看到股價的上漲速度快於市場。但是Labcorp Holdings Inc.(紐約證券交易所代碼:LH)尚未實現第二個目標,股價在五年內上漲了37%,低於市場回報率。僅從去年來看,該股就上漲了12%。

In light of the stock dropping 3.4% in the past week, we want to investigate the longer term story, and see if fundamentals have been the driver of the company's positive five-year return.

鑑於該股在過去一週下跌了3.4%,我們想調查長期情況,看看基本面是否是公司五年正回報的驅動力。

To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

用本傑明·格雷厄姆的話來說:從短期來看,市場是一臺投票機器,但從長遠來看,它是一臺稱重機。通過比較每股收益(EPS)和一段時間內的股價變化,我們可以了解投資者對公司的態度是如何隨着時間的推移而變化的。

During five years of share price growth, Labcorp Holdings actually saw its EPS drop 7.4% per year.

在五年的股價增長中,Labcorp Holdings的每股收益實際上每年下降7.4%。

This means it's unlikely the market is judging the company based on earnings growth. Because earnings per share don't seem to match up with the share price, we'll take a look at other metrics instead.

這意味着市場不太可能根據收益增長來評判該公司。由於每股收益似乎與股價不符,因此我們將改用其他指標。

The modest 1.2% dividend yield is unlikely to be propping up the share price. It is not great to see that revenue has dropped by 0.6% per year over five years. It certainly surprises us that the share price is up, but perhaps a closer examination of the data will yield answers.

1.2%的適度股息收益率不太可能支撐股價。看到收入在五年內每年下降0.6%,這並不令人滿意。股價上漲無疑使我們感到驚訝,但也許仔細研究數據會得出答案。

You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image).

您可以在下面看到收入和收入如何隨着時間的推移而變化(點擊圖片了解確切的值)。

big
NYSE:LH Earnings and Revenue Growth November 21st 2024
紐約證券交易所:LH 收益和收入增長 2024 年 11 月 21 日

Labcorp Holdings is a well known stock, with plenty of analyst coverage, suggesting some visibility into future growth. So we recommend checking out this free report showing consensus forecasts

Labcorp Holdings是一隻知名股票,有大量分析師報道,這表明未來增長有一定的可見性。因此,我們建議您查看這份顯示共識預測的免費報告

What About Dividends?

那股息呢?

When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. In the case of Labcorp Holdings, it has a TSR of 65% for the last 5 years. That exceeds its share price return that we previously mentioned. And there's no prize for guessing that the dividend payments largely explain the divergence!

在考慮投資回報時,重要的是要考慮股東總回報(TSR)和股價回報率之間的差異。儘管股價回報率僅反映股價的變化,但股東總回報率包括股息的價值(假設已進行再投資)以及任何折扣融資或分拆的收益。可以公平地說,股東總回報率爲支付股息的股票提供了更完整的畫面。就Labcorp Holdings而言,其在過去5年的股東總回報率爲65%。這超過了我們之前提到的其股價回報率。而且,猜測股息支付在很大程度上解釋了這種分歧是沒有好處的!

A Different Perspective

不同的視角

Labcorp Holdings shareholders gained a total return of 14% during the year. But that return falls short of the market. The silver lining is that the gain was actually better than the average annual return of 10% per year over five year. This suggests the company might be improving over time. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Consider for instance, the ever-present spectre of investment risk. We've identified 2 warning signs with Labcorp Holdings , and understanding them should be part of your investment process.

Labcorp Holdings的股東在年內獲得了14%的總回報。但是這種回報不及市場。一線希望是,收益實際上好於五年內每年10%的平均年回報率。這表明隨着時間的推移,該公司可能會有所改善。我發現將長期股價視爲業務績效的代表非常有趣。但是,要真正獲得見解,我們還需要考慮其他信息。例如,投資風險的幽靈無處不在。我們已經向Labcorp Holdings確定了兩個警告信號,了解它們應該是您投資過程的一部分。

We will like Labcorp Holdings better if we see some big insider buys. While we wait, check out this free list of undervalued stocks (mostly small caps) with considerable, recent, insider buying.

如果我們看到一些大規模的內幕收購,我們會更喜歡Labcorp Holdings。在我們等待的同時,請查看這份被低估的股票(主要是小盤股)的免費清單,這些股票最近有大量的內幕買盤。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

請注意,本文引用的市場回報反映了目前在美國交易所交易的股票的市場加權平均回報率。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?擔心內容嗎?直接聯繫我們。或者,發送電子郵件給編輯組(網址爲)simplywallst.com。
Simply Wall St 的這篇文章本質上是籠統的。我們僅使用公正的方法提供基於歷史數據和分析師預測的評論,我們的文章並非旨在提供財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不會考慮最新的價格敏感型公司公告或定性材料。華爾街只是沒有持有上述任何股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論